EUVIMEDEUVIMED entdecken
Crossref

A nomogram to predict the pathological complete response in patients with breast cancer based on the TILs-US score

Hideo Shigematsu iD, Kayo Fukui, Akiko Kanou, Mutsumi Fujimoto, Kanako Suzuki, Haruka Ikejiri, Ai Amioka, Emiko Hiraoka, Shinsuke Sasada, Akiko Emi, Koji Arihiro, Morihito Okada iD

Japanese Journal of Clinical Oncology · 2024

DOI: 10.1093/jjco/hyae076 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, 2024. Verfasst von Hideo Shigematsu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3-Kasumi, Minami-ku, Hiroshima, 734…. Hauptthemen laut MEDLINE: Breast Neoplasms, Nomograms, Lymphocytes, Tumor-Infiltrating, Neoadjuvant Therapy. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The tumor-infiltrating lymphocytes-ultrasonography score is a calculation system for predicting lymphocyte-predominant breast cancers in surgical specimens. A nomogram based on the tumor-infiltrating lymphocytes-ultrasonography score was developed to predict the pathological complete response in breast cancer treated with neoadjuvant chemotherapy.

Methods

A retrospective evaluation was conducted on 118 patients with breast cancer treated with neoadjuvant chemotherapy at Hiroshima University Hospital. Tumor-infiltrating lymphocytes-ultrasonography scores ≥4 were classified as high. A nomogram was developed using a stepwise logistic regression model for pathological complete response (ypT0 ypN0), based on the smallest Akaike information criterion. The predictive ability and clinical usefulness of the nomogram were also evaluated.

Results

Among 118 patients, 34 (28.8%) achieved a pathological complete response, and 52 (44.1%) exhibited high tumor-infiltrating lymphocytes-ultrasonography. In multivariate logistic regression analysis, high tumor-infiltrating lymphocytes-ultrasonography (odds ratio, 6.01; P < 0.001), clinical complete response (odds ratio, 4.83; P = 0.004) and hormone receptor (odds ratio, 3.48; P = 0.038) were independent predictors of pathological complete response. A nomogram based on tumor-infiltrating lymphocytes-ultrasonography score, clinical complete response, hormone receptor and clinical N status was developed. The nomogram showed an area under the curve of 0.831 and a bias-corrected area under the curve of 0.809. The calibration plot showed a good fit between the expected and actual pathological complete response values. Decision curve analysis also showed the clinical utility of the nomogram for predicting pathological complete responses.

Conclusions

A nomogram based on the tumor-infiltrating lymphocytes-ultrasonography score exhibited a favorable predictive ability for pathological complete response in patients with breast cancer, which can be useful in predicting the residual disease status after neoadjuvant chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNomogramsLymphocytes, Tumor-InfiltratingNeoadjuvant TherapyHumansFemaleMiddle AgedRetrospective StudiesAdultAgedPrognosisAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

breast neoplasmsneoadjuvant chemotherapynomogrampathological complete responsetumor-infiltrating lymphocytes

Autor:innen und Institutionen

  • Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, 1-2-3-Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Division of Laboratory Medicine, Hiroshima University Hospital, 1-2-3-Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
  • Department of Breast Surgery, Hiroshima City North Medical Center, Asa Citizens Hospital, 1-2-1-Kameyamaminami Asakita-ku, Hiroshima, 731-0293, Japan.
  • Department of Anatomical Pathology, Hiroshima University Hospital, 1-2-3-Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

ORCID-Profile: Hideo Shigematsu, Morihito Okada

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Shigematsu, H., Fukui, K., Kanou, A., Fujimoto, M., Suzuki, K., Ikejiri, H., Amioka, A., Hiraoka, E., Sasada, S., Emi, A., Arihiro, K., & Okada, M. (2024). A nomogram to predict the pathological complete response in patients with breast cancer based on the TILs-US score. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyae076

Vancouver

Shigematsu H, Fukui K, Kanou A, Fujimoto M, Suzuki K, Ikejiri H, et al. A nomogram to predict the pathological complete response in patients with breast cancer based on the TILs-US score. Japanese Journal of Clinical Oncology. 2024. doi:10.1093/jjco/hyae076

BibTeX
@article{Shigematsu2024,
  author = {Shigematsu, Hideo and Fukui, Kayo and Kanou, Akiko and Fujimoto, Mutsumi and Suzuki, Kanako and Ikejiri, Haruka and Amioka, Ai and Hiraoka, Emiko and Sasada, Shinsuke and Emi, Akiko and Arihiro, Koji and Okada, Morihito},
  title = {A nomogram to predict the pathological complete response in patients with breast cancer based on the TILs-US score},
  journal = {Japanese Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1093/jjco/hyae076}
}
Kostenlos starten →